These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37338616)

  • 1. Diagnosis and Management of Hepatitis Delta Virus Infection.
    Pan C; Gish R; Jacobson IM; Hu KQ; Wedemeyer H; Martin P
    Dig Dis Sci; 2023 Aug; 68(8):3237-3248. PubMed ID: 37338616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural course and treatment of hepatitis D virus infection.
    Hsieh TH; Liu CJ; Chen DS; Chen PJ
    J Formos Med Assoc; 2006 Nov; 105(11):869-81. PubMed ID: 17098688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees.
    Engle RE; De Battista D; Danoff EJ; Nguyen H; Chen Z; Lusso P; Purcell RH; Farci P
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis delta virus diagnosis.
    Olivero A; Smedile A
    Semin Liver Dis; 2012 Aug; 32(3):220-7. PubMed ID: 22932970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
    Razavi HA; Buti M; Terrault NA; Zeuzem S; Yurdaydin C; Tanaka J; Aghemo A; Akarca US; Al Masri NM; Alalwan AM; Aleman S; Alghamdi AS; Alghamdi S; Al-Hamoudi WK; Aljumah AA; Altraif IH; Asselah T; Ben-Ari Z; Berg T; Biondi MJ; Blach S; Braga WSM; Brandão-Mello CE; Brunetto MR; Cabezas J; Cheinquer H; Chen PJ; Cheon ME; Chuang WL; Coffin CS; Coppola N; Craxi A; Crespo J; De Ledinghen V; Duberg AS; Etzion O; Ferraz MLG; Ferreira PRA; Forns X; Foster GR; Gaeta GB; Gamkrelidze I; García-Samaniego J; Gheorghe LS; Gholam PM; Gish RG; Glenn J; Hercun J; Hsu YC; Hu CC; Huang JF; Janjua N; Jia J; Kåberg M; Kaita KDE; Kamal H; Kao JH; Kondili LA; Lagging M; Lázaro P; Lazarus JV; Lee MH; Lim YS; Marotta PJ; Navas MC; Naveira MCM; Orrego M; Osiowy C; Pan CQ; Pessoa MG; Raimondo G; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Ríos-Hincapié CY; Rodríguez M; Rosenberg WMC; Roulot DM; Ryder SD; Safadi R; Sanai FM; Santantonio TA; Sarrazin C; Shouval D; Tacke F; Tergast TL; Villalobos-Salcedo JM; Voeller AS; Yang HI; Yu ML; Zuckerman E;
    J Hepatol; 2023 Aug; 79(2):576-580. PubMed ID: 37030400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis D virus coinfection and superinfection.
    Negro F
    Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a021550. PubMed ID: 25368018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis delta virus testing, epidemiology and management: a multicentre cross-sectional study of patients in London.
    El Bouzidi K; Elamin W; Kranzer K; Irish DN; Ferns B; Kennedy P; Rosenberg W; Dusheiko G; Sabin CA; Smith BC; Nastouli E
    J Clin Virol; 2015 May; 66():33-7. PubMed ID: 25866333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
    Gheorghe L; Csiki IE; Iacob S; Gheorghe C; Trifan A; Grigorescu M; Motoc A; Suceveanu A; Curescu M; Caruntu F; Sporea I; Brisc C; Rogoveanu I; Cerban R; Tugui L; Alexandrescu A
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):413-21. PubMed ID: 26697566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
    Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
    J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.
    Chen X; Oidovsambuu O; Liu P; Grosely R; Elazar M; Winn VD; Fram B; Boa Z; Dai H; Dashtseren B; Yagaanbuyant D; Genden Z; Dashdorj N; Bungert A; Dashdorj N; Glenn JS
    Hepatology; 2017 Dec; 66(6):1739-1749. PubMed ID: 27880976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers.
    Pol S; Wesenfelder L; Dubois F; Roingeard P; Carnot F; Driss F; Brechot C; Goudeau A; Berthelot P
    J Viral Hepat; 1994; 1(2):131-7. PubMed ID: 8790568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.
    Huang CR; Lo SJ
    World J Gastroenterol; 2014 Oct; 20(40):14589-97. PubMed ID: 25356023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic.
    Sagnelli C; Pisaturo M; Curatolo C; Codella AV; Coppola N; Sagnelli E
    World J Gastroenterol; 2021 Nov; 27(42):7271-7284. PubMed ID: 34876788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
    Ferrante ND; Lo Re V
    Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hepatitis delta superinfection when investigating transaminitis in HIV/hepatitis B virus co-infection.
    Hamady A; Cooke GS; Garvey LJ
    AIDS; 2021 Aug; 35(10):1704-1706. PubMed ID: 33973877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
    Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
    Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The epidemiology and screening of hepatitis D].
    Xue F; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1017-1021. PubMed ID: 36727224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis delta: virological and clinical aspects.
    Botelho-Souza LF; Vasconcelos MPA; Dos Santos AO; Salcedo JMV; Vieira DS
    Virol J; 2017 Sep; 14(1):177. PubMed ID: 28903779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.